Pharmaceutical formulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8506998
APP PUB NO 20070098795A1
SERIAL NO

11640749

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A solid, oral controlled release pharmaceutical dosage form has a water-soluble active ingredient dispersed in a matrix and releases the active ingredient at such a rate upon administration that the median tmax is 2.5 to 6 hours and the ratio of mean Cmax to mean plasma level of the active ingredient at 24 hours is in the range of 1.5 to 3.5.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • EURO-CELTIQUE S.A.

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Knott, Trevor John Bishops Stortford, GB 11 1390
Leslie, Stewart Thomas Cambridge, GB 21 2593
Malkowska, Sandra Therese Antoinette Ely, GB 16 2198
Miller, Ronald Brown Basle, CH 18 2400
Mohammad, Hassan Haslingfield, GB 28 900
Prater, Derek Allan Milton, GB 33 2789

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 13, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00